Here are five recent statistics that illustrate the mounting supply chain pressures facing ASCs and other healthcare providers:
1. Medical supply chain costs are projected to increase 2.41% in 2026.
2. Supply costs accounted for 13% of hospitals’ expenses in 2024.
3. Healthcare analytics company Vizient predicted a 3.35% rise in pharmaceutical prices in 2026, driven by a surge in the use of high-cost therapies like GLP-1s and CAR-T treatments.
4. About 250 medications are already in shortage nationwide, and this number could get worse if tariffs are implemented by President Donald Trump.
5. A recent analysis from GlobalData found that about 70% of medical devices marketed in the U.S. are manufactured solely overseas.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.